33: Drug Action on Adrenergic Neurotransmitters Flashcards

1
Q

Draw the structure of norepinephrine.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Draw the structure of epinephrine

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where is norepinephrine produced? What is it used for?

A

Produced in the **locus coeruleus **in the back of the pons and distibuted in various areas in the brain.
* released in response to stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the function of adrenergic neurotransmitters in the sympathetic nervous system.

A

Sympathetic activation of the adrenal glands –> adrenal medulla releases norepinephrine and epinephrine into the bloodstream –> functions as a hormone to further access to a wide variety of tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the function of adrenergic neurotransmitters in the eyes?

A

An increase in production of tears –> making the eyes more moist and pupil dilation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the function of adrenergic neurotransmitters in the lungs?

A

An increase in bronchodilation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the function of adrenergic neurotransmitters in the heart?

A

An increase in the amount of blood pumped.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the function of adrenergic neurotransmitters in the arteries?

A

Constriction of blood vessels –> causing an increase in blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the function of adrenergic neurotransmitters in the stomach and intestines?

A

A reduction in digestive activity due to decreases in gastrointestinl mobility, blood flow, and secretion of digestive substances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the function of adrenergic neurotransmitters in the stomach and intestines?

A

A reduction in digestive activity due to decreases in gastrointestinl mobility, blood flow, and secretion of digestive substances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the function of adrenergic neurotransmitters in the liver?

A

An increase in production of glucose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the function of adrenergic neurotransmitters in the kidneys?

A

Release of renin and retention of sodium in the bloodstream.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the function of adrenergic neurotransmitters in the pancreas?

A

Increased release of glucagon
* glucagon - a hormone that increases the production of glucose by the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the function of adrenergic neurotransmitters in the adipose tissue?

A

An increase in lipolysis
* lipolysis - conversion of fat to substances that can be used directly as energy sources by muscles and other tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the function of adrenergic neurotransmitters on the bladder?

A

Increase in contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the function of adrenergic neurotransmitters on the uterus?

A

Increase of activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain the negative outcomes of reduced norepinephrine hormone levels.

A
  • depression
  • poor memory
  • lack of energy
  • lack of concentration
  • lack of motivation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Explain the consequences of increased norepinephrine hormone levels.

A
  • increased blood pressure
  • increased heart rate
  • hyperactive
  • anxiety and stress
  • irritability and insomnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the human diseases associated with high levels of norepinephrine and epinephrine.

A

Sympathetic hyperactivation: a distinctive set of symptoms including…
* aches and pains
* rapid heartbeat
* elevated blood pressure
* sweating
* palpitations
* anxiety

Stress: increases when increase of norepinephrine activity, which mobilizes the brain and body to meet the threat

Tumor of the adrenal medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the human diseases associated with high levels of norepinephrine and epinephrine.

A

Sympathetic hyperactivation: a distinctive set of symptoms including…
* aches and pains
* rapid heartbeat
* elevated blood pressure
* sweating
* palpitations
* anxiety

Stress: increases when increase of norepinephrine activity, which mobilizes the brain and body to meet the threat

Tumor of the adrenal medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the human diseases associated with low levels of norepinephrine and epinephrine.

A

ADHD: a psychiatric condition involving problems with attention, hyperactivity, and impulsiveness

22
Q

Explain the different effects of drug action on adrenergic neurotransmitters.

A

Altering..
* biosynthesis of presynaptic neuron
* release from a presynaptic neuron to a synaptic cleft
* uptake back to a presynaptic neuron
* removal in a synaptic cleft

23
Q

Explain where biosynthesis of adrenergic neurotransmitters begins.

A

Starts from tyrosine
* tyrosine is a natural amino acid in proteins

24
Q

Explain aderenergic neurotransmitter biosynthesis: step 1.

A

Tyrosine is taken into the presynaptic neuron by Na+-dependent tyrosine transporter.

25
Q

Explain aderenergic neurotransmitter biosynthesis: step 2.

A

Tyrosine is hydroxylated into DOPA by tyrosine hydroxylase (TH)
* a rate-limiting step

26
Q

Explain aderenergic neurotransmitter biosynthesis: step 3.

A

DOPA is converted into dopamine by DOPA decarboxylase (DDC)

27
Q

Explain aderenergic neurotransmitter biosynthesis: step 4 (storage).

A

Dopamine is taken into presynaptic vesicles by a H+-coupled vesicular monoamine transporter (VMAT).

28
Q

Explain aderenergic neurotransmitter biosynthesis: step 5.

A

Dopamine is hydroxylated into norepinephrine (NE) by dopamine beta-hydroxylase (DBH).

29
Q

Explain aderenergic neurotransmitter biosynthesis: step 6.

A

Norepinephrine is methylated into epinephrine by PNMT.

30
Q

Explain aderenergic neurotransmitter biosynthesis: step 7 (release).

A

Vesicles move to the presynaptic terminal, which enforces Ca2+ channel to open and uptake of Ca2+ into the neuron.

31
Q

Explain aderenergic neurotransmitter biosynthesis: step 8 (release)

A

Ca2+ ions activate the vesicles to fuse with the presynaptic membrane and release norepinephrine into the synaptic cleft.
* fusion process and release of norepinephrine can be inhibited by bretylium and guanethidine.

32
Q

Explain aderenergic neurotransmitter biosynthesis: step 9 (removal)

A

A part of norepinephrine is diffused out of the synaptic cleft.

33
Q

Explain aderenergic neurotransmitter biosynthesis: step 10 (reuptake)

A

A part of norepinephrine is retaken by NaCl-dependent norepinephrine transporter (NET)
* NET can be inhibited by cocaine and tricyclic antidepressants (TCAs)

34
Q

Explain aderenergic neurotransmitter biosynthesis: step 11 (degradation)

A

A part of norepinephrine is metabolized into nometanephrine by COMT –> form inactive metabolite secreted into urine.

35
Q

Explain aderenergic neurotransmitter biosynthesis: step 11 (degradation)

A

A part of norepinephrine is metabolized into nometanephrine by COMT –> form inactive metabolite secreted into urine.

36
Q

Explain aderenergic neurotransmitter biosynthesis: step 12 (degradation)

A

A part of reuptake norepinephrine is metabolized into DOPGAL by MAO –> form inactive metabolite secreted into urine.

37
Q

Explain the negative feedback mechanism of norepinephrine release.

A

A part of norepinephrine binds to the presynaptic neuron on the neuron membrane surface –> inhibits neurotransmitter release from the vesicles by a negative feedback mechanism.

38
Q

Metirosine
drug action:
target protein:
therapeutic indication:

A

drug action: inhibition of biosynthesis
target protein: TH
therapeutic indication: hypertension

39
Q

Carbidopa
drug action:
target protein:
therapeutic indication:

A

drug action: inhibition of biosynthesis
target protein: DDC
therapeutic indication: parkinson’s

40
Q

Reserpine
drug action:
target protein:
therapeutic indication:

A

drug action: inhibition of storage
target protein: VMAT
therapeutic indication: hypertension

41
Q

Guanethidine
drug action:
target protein:
therapeutic indication:

A

drug action: inhibition of release
target protein: fusion process
therapeutic indication: hypertension

42
Q

Bretylium
drug action:
target protein:
therapeutic indication:

A

drug action: inhibition of release
target protein: fusion process
therapeutic indication: arrhythmic

43
Q

Cocaine
drug action:
target protein:
therapeutic indication:

A

drug action: inhibition of reuptake
target protein: NET
therapeutic indication: pain management

44
Q

Tricyclic antidepressants
drug action:
target protein:
therapeutic indication:

A

drug action: inhibition of reuptake
target protein: NET
therapeutic indication: antidepressant

45
Q

Entacapone
drug action:
target protein:
therapeutic indication:

A

drug action: inhibition of degradation
target protein: COMT
therapeutic indication: parkinson’s disease

46
Q

Selegiline
drug action:
target protein:
therapeutic indication:

A

drug action: inhibition of degradation
target protein: MAO
therapeutic indication: antidepressant

47
Q
A
48
Q
A
49
Q
A
50
Q
A